[An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease]
- PMID: 2192210
[An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease]
Similar articles
-
[Parkinsonism and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (review of the literature)].Zh Nevropatol Psikhiatr Im S S Korsakova. 1991;91(4):117-21. Zh Nevropatol Psikhiatr Im S S Korsakova. 1991. PMID: 1650080 Review. Russian. No abstract available.
-
[Mechanism of induction of parkinsonism by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a dopaminergic neurotoxin].Tanpakushitsu Kakusan Koso. 1986 Apr;31(5):398-409. Tanpakushitsu Kakusan Koso. 1986. PMID: 3520683 Review. Japanese. No abstract available.
-
Metabolic aspects of the behavior of MPTP and some analogues.Adv Neurol. 1993;60:186-93. Adv Neurol. 1993. PMID: 8420134 Review. No abstract available.
-
Neurochemical and behavioral effects of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in rat, guinea pig, and monkey.Psychopharmacol Bull. 1984 Summer;20(3):548-53. Psychopharmacol Bull. 1984. PMID: 6332333 No abstract available.
-
[MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) and parkinsonism].Sheng Li Ke Xue Jin Zhan. 1989 Apr;20(2):161-3. Sheng Li Ke Xue Jin Zhan. 1989. PMID: 2686017 Review. Chinese. No abstract available.